Evidence map›Paper›PMID 42494259›Full record

ArticleGlia2026

Cdk7 Regulates Myelin Sheath Morphology and Lipid Homeostasis in Schwann Cells.

Nathalie Schumacher, Alexandra Pieltain, Pierre Tocquin, Nicolas Thelen, Arnaud Lavergne, Nathalie Masar, Romano Terrasi, Romane Leloup, Giulio Muccioli, Philippe Gailly and 3 more

Abstract read
In one paragraph

Article in Glia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nathalie SchumacherLaboratory of Nervous System Disorders and Therapies, GIGA Institute, Université de Liège, Liège, Belgium.ORCID https://orcid.org/0009-0006-6582-5339
Alexandra PieltainLaboratory of Nervous System Disorders and Therapies, GIGA Institute, Université de Liège, Liège, Belgium.
Pierre TocquinCARE PhytoSYSTEMS, Integrative Biological Sciences, Université de Liège, Liège, Belgium.ORCID https://orcid.org/0000-0002-1302-6504
Nicolas ThelenLaboratory of Cellular and Tissular Biology, GIGA Institute, Université de Liège, Liège, Belgium.ORCID https://orcid.org/0000-0001-8042-1275
Arnaud LavergneGIGA Bioinformatics Platform, GIGA Institute, Université de Liège, Liège, Belgium.ORCID https://orcid.org/0000-0003-4817-3202
Nathalie MasarLaboratory of Nervous System Disorders and Therapies, GIGA Institute, Université de Liège, Liège, Belgium.ORCID https://orcid.org/0009-0009-3921-4990
Romano TerrasiBioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.ORCID https://orcid.org/0009-0000-5974-4491
Romane LeloupBioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.ORCID https://orcid.org/0000-0001-8957-557X
Giulio MuccioliBioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.ORCID https://orcid.org/0000-0002-1600-9259
Philippe GaillyLaboratory of Cell Physiology, Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium.ORCID https://orcid.org/0000-0002-9259-3813
Peter Arthur-FarrajDepartment of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0002-1239-9392
Renaud VandenboschLaboratory of Developmental Neurobiology, GIGA Institute, Université de Liège, Liège, Belgium.ORCID https://orcid.org/0000-0003-4887-9870
Rachelle FranzenLaboratory of Nervous System Disorders and Therapies, GIGA Institute, Université de Liège, Liège, Belgium.ORCID https://orcid.org/0000-0001-7336-791X

Funding

Belgian National Funds for Scientific Reserarch (F.R.S.-FNRS) J.0059.23Faculty of Medicine, University of LiegeFonds Léon Fredericq
6 · The paper itself

Abstract

Schwann cells (SC) are responsible for myelination in the peripheral nervous system (PNS). Myelin allows saltatory transmission of action potentials along axons and functionally relies on its unique constitution. We previously reported that Cdk7, a regulator of cell cycle progression and transcription, regulates myelin gene expression in oligodendrocytes and contributes to myelin maintenance in the central nervous system. Using mice with conditional Cdk7 knock-out in SCs, we provide evidence that Cdk7 is dispensable for myelin initiation but needed for the correct myelin thickness of larger caliber fibers in young mice, as well as for myelin elongation and rapid nerve conduction throughout age. We report that Cdk7 loss results in disturbed myelin stoichiometry, with significant dysregulation of lipid-related genes in SCs and a reduction in myelin protein zero. Finally, we demonstrate that Rxrγ, a nuclear receptor involved in lipid metabolism, is significantly downregulated in the absence of Cdk7. However, although Cdk7 regulates myelin segment length, our results indicate that this effect occurs independently of Rxrγ in myelinating dorsal root ganglion explants.

Indexed as

Cyclin-Dependent KinasesHomeostasisLipid MetabolismMyelin SheathSchwann CellsAnimalsCyclin-Dependent Kinase-Activating KinaseGanglia, SpinalMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMyelin P0 ProteinNerve Conduction StudiesNeural ConductionCyclin-Dependent Kinase-Activating KinaseCyclin-Dependent KinasesMyelin P0 ProteinCdk7lipidsmyelinSchwann cells

Identifiers

PMID42494259
PMCPMC13396973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.